SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emami Ltd (EMAMILTD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531162 NSE: EMAMILTD Household & Personal Products | Small Cap | Emami Share Price

₹385.20 -5.65 (-1.45%)

As on 05-Jun'26 16:59

Emami Ltd (EMAMILTD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531162 NSE: EMAMILTD Household & Personal Products | Small Cap | Emami Share Price

₹385.20 -5.65 (-1.45%)

As on 05-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹17,061 Cr.
Current Price
₹385.2
52-Week Low / High
₹380 / 635
TTM EPS
₹17.8
TTM Sales
₹3,780 Cr.
Book Value per Share
₹67
P/E Ratio
22.01
Lower than its 5-year historical median
Industry PE
44.9
Price to Book (P/B)
5.83
Lower than its 5-year historical median
Price to Sales (P/S)
4.51
Lower than its 5-year historical median
EV/EBITDA
15.99
Lower than its 5-year historical median
Dividend Yield
1.73%
Profitability Efficiency
Return on Equity (ROE)
31.23%
Outperforms industry median
Return on Capital Employed (ROCE)
34.28%
Outperforms industry median
Return on Assets (ROA)
27.44%
Operating Profit Margin
26.9%
Net Profit Margin
21.07%
Gross Profit Margin
28.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
6.46%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
7.96%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
10.85%
Asset Quality
Promoter Holding
54.84%
Pledged shares (%) of Promoter's holding (%)
16.43%
Reserves
₹2,880 Cr.
Equity
₹43.7 Cr.
Face Value
₹1
All Time Low / High
₹2.34 / 859.20

Emami stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Emami Ltd a good quality company?
Emami Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Emami Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Emami Ltd vs industry peers?
Emami Ltd revenue CAGR is 7.49%, compared to the industry median CAGR of 2.59%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Emami Ltd?
Promoters hold 54.84% of the Emami Ltd, with 16.43% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Emami Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -2.8% based on the current price.

DeciZen - make an informed investing decision on Emami

Decision Maker
Consolidated basis

1. Right Stock

Login to view analysis.

2. Right Price

3. Right Time

#Likely Future 5 Year CAGR.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Emami Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 26.9%21.4%18.7%18.8%18.7%29.9%33%28.7%32.8%34.3%-
Value Creation
Index
1.40.90.70.40.41.71.91.11.42.1-

Growth Parameters

Sales 2,3582,4882,5312,6952,6552,8813,1873,4063,5783,8093,780
Sales YoY Gr.-5.5%1.7%6.5%-1.5%8.5%10.7%6.9%5.1%6.5%-
Adj EPS 8.78.37.96.86.810.31914.416.618.517.8
YoY Gr.--5.2%-4.5%-13.5%-0.3%50.4%85.6%-24.5%15.7%11.1%-
BVPS (₹) 35.538.744.445.740.239.747.152.256.161.767
Adj Net
Profit
396376359310309456840634726807775
Cash Flow from Ops. 562730588554531922644749779896-
Debt/CF from Ops. 1.20.70.60.20.40.10.40.10.10.1-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 5.5%7.5%6.1%6.5%
Adj EPS 8.7%22.1%-1%11.1%
BVPS6.3%8.9%9.5%10.2%
Share Price -2.8% -6.5% -0.8% -33.9%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
27.922.319.115.215.925.443.82930.631.427.6
Op. Profit
Mgn %
29.230.528.527.126.230.729.925.326.626.925.5
Net Profit
Mgn %
16.815.114.211.511.615.826.318.320.321.120.5
Debt to
Equity
0.40.30.20.10.10.10.10000
Working Cap
Days
6465718711310810210810710399
Cash Conv.
Cycle
-5-16815141318201660

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales2,3582,4882,5312,6952,6552,8813,1873,4063,5783,809
Operating Expenses + 1,7361,7871,8881,9671,9641,9972,2352,5432,6292,784
Manufacturing Costs37475160615865747675
Material Costs8127918109238769291,0731,2011,1611,194
Employee Cost 208234255280300309318368396447
Other Costs 6797157727047287017799009971,067
Operating Profit 6237016437276918839528639501,025
Operating Profit Margin (%) 26.4%28.2%25.4%27.0%26.0%30.7%29.9%25.3%26.5%26.9%
Other Income + 109899635577095694768
Exceptional Items 000-10-110-50-60
Interest 54583421211357109
Depreciation 255309311325336367335247186178
Profit Before Tax 423424393403374569688670791894
Tax 60848610171114-149426791
Profit After Tax 363340306303302455837627724803
PAT Margin (%) 15.4%13.7%12.1%11.2%11.4%15.8%26.3%18.4%20.2%21.1%
Adjusted EPS (₹)8.07.56.86.76.710.219.014.516.618.5
Dividend Payout Ratio (%)43.70%46.70%51.70%59.90%59.80%78.20%42.10%55.20%48.30%54.10%

Valuation of Emami - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1,6121,7552,0142,0761,8241,7632,0772,3032,4472,695
Share Capital 23232345454444444444
Reserves 1,5891,7321,9912,0311,7781,7182,0322,2592,4032,651
Debt +67117332611021092264746662
Long Term Debt300000000000
Short Term Debt37117332611021092264746662
Minority Interest411-0-1-1-21011-1
Trade Payables249185242291324351409407455436
Others Liabilities 15648921634132131527-47-136-181
Total Liabilities 2,6922,6032,7982,8192,6782,5202,7742,7462,8423,010

Fixed Assets

Net Fixed Assets +1,9181,9401,7461,6251,4051,0791,2901,1921,062933
Gross Block2,3552,4992,6192,8152,9302,9643,4953,6273,6653,696
Accumulated Depreciation4375608731,1901,5251,8852,2052,4352,6042,763
CWIP 672230368636815
Investments 47128314187156255303293442676
Inventories151179194222245300358328323308
Trade Receivables13197156216308232321415494451
Cash Equivalents 1085080203119360116185201273
Others Assets 270188278328438287384327312353
Total Assets 2,6922,6032,7982,8192,6782,5202,7742,7462,8423,010

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 562730588554531922644749779896
PBT 423424393403374569688670791894
Adjustment 291354337317313330268208168141
Changes in Working Capital -5623-61-74-80109-169-11-3446
Tax Paid -96-71-81-93-76-86-143-117-146-185
Cash Flow From Investing Activity + -1,306-297-279-23-228-227-235-113-205-340
Capex -1,814-281-123-133-148-32-480-30-29-43
Net Investments 426-90-24092-30-287223-92-175-308
Others 82748417-5092239-211
Cash Flow From Financing Activity + 502-496-324-428-405-688-402-608-563-500
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -52-58-34-21-21-13-4-6-10-9
Dividend Paid -68-199-119-159-363-356-356-353-349-349
Others 622-239-170-247-21-319-42-249-204-141
Net Cash Flow -243-64-15103-10267281156

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)25.5520.216.2614.7915.525.3643.5828.6530.4931.23
ROCE (%)26.8721.3618.6918.7718.729.9433.0428.732.7634.28
Asset Turnover Ratio1.10.950.940.960.971.111.21.231.281.3
PAT to CFO Conversion(x)1.552.151.921.831.762.030.771.191.081.12
Working Capital Days
Receivable Days17.7016.5018.2025.2036.1034.2031.7039.4046.4045.30
Inventory Days21.1023.8026.8028.2032.1034.5037.7036.7033.2030.30
Payable Days99.3010096.20105.50128.30132.60129.20123.90135.50136

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *13.3313.0911.238.159.1613.3910.509.9811.6016.43
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Emami Ltd FAQs

The current trading price of Emami on 05-Jun-2026 16:59 is ₹385.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Emami stood at ₹17,060.6 Cr

The latest P/E ratio of Emami as of 04-Jun-2026 is 20.27.

The latest P/B ratio of Emami as of 04-Jun-2026 is 5.41.

The 52-week high of Emami is ₹634.6 and the 52-week low is ₹380.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Emami is ₹3,048 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Emami Ltd is a good quality company.

The key valuation ratios of Emami Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Emami Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Emami Ltd

Emami Limited is one of the leading and fastest growing personal and healthcare businesses in India, with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Mentho Plus Balm, Fast Relief and Kesh King. The Company is a public limited company domiciled in India and is primarily listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

Business area of the company

The Company is one of India’s leading FMCG Companies engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as Boro Plus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.

Products

BoroPlus

  • Ayurvedic Antiseptic Cream
  • Prickly Heat Powder
  • Doodh Kesar Body Lotion
  • Aloe Vera Gel
  • Hygiene Range

Navratna:

  • Cool Oil
  • Extra Thanda
  • Extra Thanda Hairfall Rodhak
  • Garam Ayurvedic Oil
  • Maxx Cool Talc
  • Cool

Zandu

  • Balm
  • Balm Ultra Power

Fair and Handsome

  • Fairness Cream For Men
  • Instant Fairness Face Wash
  • Complete Winter Solution
  • Laser 12

Mentho plus

  • Balm

Fast Relief

  • Pain Relief Ointment

Vasocare

  • Herbal Petroleum Jelly

Zandu

  • Healthcare OTC, Classical, Ethical
  • Nityam
  • Kesari Jivan
  • Ayurvedic Hand Sanitizer

Emami 7 Oils in One

  • Non Sticky Hair Oil

Kesh King

  • Haircare

Diamond Shine

  • Creme Hair Colour: 1.0 Natural Black; 3.0 Dark Brown; 3.66 Cherry Red; 4.0 Natural Brown and 4.16 Burgundy

HE: Deodorants

  • Passion
  • Power
  • Force
  • Intense
  • Arctic
  • Lagoon
  • Ruler
  • Innovator
  • Respect
  • Achiever
  • Magic Duo Angel & Demon
  • Magic Duo Yin & Yang

Emami Golden Beauty

  • Talc

Emami Naturally Fair

  • Herbal Fairness Cream

Awards

2018-19

  • The Institute of Internal Auditors India - Calcutta Chapter awarded the Company for its ‘Excellence in Internal Audit Function’ (in the large manufacturing sector category).
  • Emami Foundation’s Ayurveda based ‘Sanjeevani’ CSR project was awarded the ‘Kolkata CSR Leadership Awards 2018’ under the category ‘Concern for Health’.
  • Emami ranks at 18 in the list of top 50 advertisers in 2018 of Pitch magazine. (March, 2019)
  • Emami Limited has been declared as the Winner of 'Golden Peacock Innovative Product/Service Award' for the year 2019 (for ‘Kesh King Oil Applicator’)
  • Emami Limited ranked at 425th position in the Fortune India 500 2018 list from its earlier position of 402nd in 2017. In FMCG sectoral list, Emami has been ranked at 20th position out of 23 companies. (December, 2018)

2019-20

  • Awarded ‘Company of the year- FMCG’ by CNBC-Awaaz for the Company’s outstanding performance on parameters such as growth, capital efficiency and profitability over a period of time
  • Emami Group was conferred with ‘Star of the Year’ at the 10th edition of Think CSR 2019 Award organised by Tefla’s.

Milestones

  • 1974: Two childhood friends Mr RS Agarwal and Mr RS Goenka quit their jobs to start their own business, Emami
  • 1978: Acquired Himani Limited and set up factory in Kolkata
  • 1984: Boroplus Antiseptic Cream launched, under Himani umbrella
  • 1989: Navratna Cool Oil launched, under the Himani name
  • 1989: Set up second factory in Pondicherry
  • 1998: Expanded the distribution network of the company to South India
  • 1998: Emami merged with Himani Limited
  • 1999: Launch of Sona Chandi Chyawanprash
  • 2005: Launch of Fair and Handsome, the first fairness cream for men
  • 2005: Public issue of 50 lac shares, listed with NSE
  • 2006: Introduced Health Care Division
  • 2006: Merged JB Marketing
  • 2008: Successful Zandu Pharmaceuticals acquisition at Rs 730 crore
  • 2009: Demerged Zandu fmcg into Emami
  • 2009: Raised Rs 310 crore through QIP
  • 2010: Crossed net sales of Rs 1000 crore
  • 2010: Exceeded market cap of Rs 5000 crore
  • 2010: Split of shares from Rs 2 to Re 1 per share
  • 2011: Conceived setting up of its first overseas manufacturing unit in Bangladesh.
  • 2012: Signed 4 Olympians & 1 cricketer as brand endorsers for a single brand, Fast Relief
  • 2012: Started production at Bangladesh manufacturing unit
  • 2013: Bonus Issue; exceeded market capitalisation of Rs. 10,000 crore
  • 2013: Launched BoroPlus Face wash. Signed in Sonakshi Sinha for the endorsement
  • 2014: Declared Interim Dividend of Rs 3 /share
  • 2014: Entered the male deodorants space with HE , with brand ambassador, Hrithik Roshan
  • 2014: Launched Fair & Handsome- Instant Fairness Face wash
  • 2014: Launched Zandu Balm Ultra Power
  • 2014: Acquired ‘She Comfort’ brand
  • 2015: Acquired ‘Kesh King’ Business at Rs 1684 crore ( Including duties & taxes)
  • 2015: Acquired controlling stake in Fravin Pty Ltd.
  • 2015: Launched Zandu Gel Balm Junior
  • 2015: Exceeded Market Cap. Of Rs 23,000 crore
  • 2015: Launched 100% pure honey with Zero-added sugar.
  • 2016: Emami introduces Boroplus Perfect Touch to appeal to the Generation Next
  • 2016: Kesh King Introduces Sachet Pack For Its Shampoo
  • 2017: Emami Limited inaugurates its 3rd Manufacturing Unit in Assam
  • 2018: Navratna Oil launches its new winter variant: Navratna Garam Ayurvedic Tel
  • 2019: Bollywood Action Star Tiger Shroff adds 3-Ka-PunchTo Emami's HE Magic Duo
  • 2019: Emami ropes in Superstar Katrina Kaif as the new face for Emami 7 Oils in One
  • 2020: Emami Limited launches Boroplus Advanced Anti-Germ Hand Sanitizer
  • 2020: BoroPlus ropes in Juhi Chawla for its Hygiene Range
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×